Rhodium-catalyzed ring-opening reactions of N-Boc-azabenzonor-bornadiene with chiral amine nucleophiles derived from amino acids

Synthesis

Volumn , Issue 15, 2008, Pages 2467-2475

  Cho, Yong Hwan ^a   Tseng, Nai Wen ^a   Senboku, Hisanori ^a   Lautens, Mark ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diamines; Diastereoselective; Heterocycles; Rhodium; Ring opening

Indexed keywords

ACIDS; AMINATION; AMINO ACIDS; AROMATIC HYDROCARBONS; NITROGEN; NONMETALS; NUCLEOPHILES; ORGANIC ACIDS; ORGANIC COMPOUNDS; RHODIUM;

CHIRAL AMINES; DIAMINES; DIASTEREOMERS; DIASTEREOSELECTIVE; HETEROCYCLES; HIGH YIELD; NITROGEN HETEROCYCLES; R PHENYLGLYCINE; RHODIUM-CATALYZED; RING-OPENED PRODUCTS; RING-OPENING; RING-OPENING REACTIONS;

AMINES;

DIAMINE DERIVATIVE; N BOC AZABENZONOR BORNADIENE; NITROGEN; PHENYLGLYCINE; PROLINE; RHODIUM;

ARTICLE; CHEMICAL REACTION; CHIRALITY; CRYSTAL STRUCTURE; DIASTEREOISOMER; ENANTIOSELECTIVITY; RING OPENING;

EID: 49649093065     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1078596     Document Type: Article

References (68)

1. (a) Walsh, P. J. Acc. Chem. Res. 2003, 36, 739.
2. (b) Ojima, I. Catalytic Asymmetric Synthesis, 2nd ed.; VCH Publishers: Weinheim, 2000.
3. (a) Fache, F.; Schulz, E.; Tommasino, M. L.; Lemaire, M. Chem. Rev. 2000, 100, 2159.
4. (b) Denmark, S. E.; Stavenger, R. A. Acc. Chem. Res. 2000, 33, 432.
5. (c) Bennani, Y. L.; Hanessian, S. Chem. Rev. 1997, 97, 3161.
6. (d) Togni, A.; Venanzi, L. M. Angew. Chem., Int. Ed. Engl. 1994, 33, 497.
7. (e) Tomioka, K. Synthesis 1990, 541.
8. (f) Whitsell, J. K. Chem. Rev. 1989, 89, 1581.
9. (a) Baleiza, C.; Garcia, H. Chem. Rev. 2006, 106, 3987.
10. (b) Yoon, T. P.; Jacobsen, E. N. Science 2003, 299, 1691.
11. (c) Jacobsen, E. N. Acc. Chem. Res. 2000, 33, 421.
12. Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103, 2921.
13. (a) Strieter, E. R.; Blackmond, D. G.; Buchwald, S. L. J. Am. Chem. Soc. 2005, 127, 4120.
14. (b) Klapars, A.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 7421.
15. (c) Klapars, A.; Antilla, J. C.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 7727.
16. (d) Wolter, M.; Klapars, A.; Buchwald, S. L. Org. Lett. 2001, 3, 3803.
17. (a) Timerbaev, A. R.; Hartinger, C. G.; Aleksenko, S. S.; Keppler, B. K. Chem. Rev. 2006, 106, 2224.
18. (b) Reedijk, J. Chem. Commun. 1996, 801.
19. (c) Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Nature 1969, 222, 385.
20. Marquet, A. Pure Appl. Chem. 1993, 65, 1249.
21. Shinagawa, S.; Kanamaru, T.; Harada, S.; Asai, M.; Okazaki, H. J. Med. Chem. 1987, 30, 1458.
22. (a) Chang, A.-C.; Takemori, A. E.; Ojala, W. H.; Gleason, W. B.; Portoghese, P. S. J. Med. Chem. 1994, 37, 4490.
23. (b) Weerawarna, S. A.; Davis, R. D.; Nelson, W. L. J. Med. Chem. 1994, 37, 2856.
24. (c) Michalson, E. T.; Szmuszkovicz, J. Prog. Drug. Res. 1989, 33, 135.
25. (d) Rees, D. C. Prog. Med. Chem. 1992, 29, 109.
26. (e) Scopes, D. I. C.; Hayes, N. F.; Bays, D. E.; Belton, D.; Brain, J.; Brown, D. S.; Judd, D. B.; McElroy, A. B.; Meerholtz, C. A.; Naylor, A.; Hayes, A. G.; Sheehan, M. J.; Birch, P. J.; Tyers, M. B. J. Med. Chem. 1992, 35, 490.
27. (f) Rajagopalan, P.; Scribner, R. M.; Pennev, P.; Mattei, P. L.; Kezar, H. S.; Cheng, C. Y.; Cheeseman, R. S.; Ganti, V. R.; Johnson, A. L.; Wuonola, M. A.; Schmidt, W. K.; Tam, S. W.; Steinfels, G. F.; Cook, L. Bioorg. Med. Chem. Lett. 1992, 2, 721.
28. (g) Vecchietti, V.; Giordani, A.; Giardina, G.; Colle, R.; Clark, G. D. J. Med. Chem. 1991, 34, 397.
29. (h) Halfpenny, P. R.; Horwell, D. C.; Hughes, J.; Humblet, C.; Hunter, J. C.; Neuhaus, D.; Rees, D. C. J. Med. Chem. 1991, 34, 190.
30. (i) Costello, G. F.; Main, B. G.; Barlow, J. J.; Carroll, J. A.; Shaw, J. S. Eur. J. Pharmacol. 1988, 151, 475.
31. (a) Hettinger, T. P.; Craig, L. C. Biochemistry 1970, 9, 1224.
32. (b) Yoshioka, H.; Aoki, T.; Goko, H.; Nakatsu, K.; Noda, T.; Sakakibara, H.; Take, T.; Nagata, A.; Abe, J.; Wakamiya, T.; Shiba, T.; Kaneko, T. Tetrahedron Lett. 1971, 2043.
33. (c) Umezawa, H.; Maeda, K.; Takeuchi, T.; Okami, Y. J. Antibiot. Ser. A 1966, 19, 200.
34. Comprehensive Heterocyclic Chemistry, Vol. 2; Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Elsevier: Amsterdam, 1996.
35. (a) Yoon, S. S.; Still, W. C. J. Am. Chem. Soc. 1993, 115, 823.
36. (b) Torneiro, M.; Still, W. C. Tetrahedron 1997, 53, 8739.
37. (a) Westermann, B. Angew. Chem. Int. Ed. 2003, 42, 151; and references cited therein.
38. (b) Lucet, D.; Le Gall, T.; Mioskowski, C. Angew. Chem. Int. Ed. 1998, 37, 2580; and references cited therein.
39. (a) Cho, Y.-H.; Zunic, V.; Senboku, H.; Olsen, M.; Lautens, M. J. Am. Chem. Soc. 2006, 128, 6837.
40. (b) Lautens, M.; Fagnou, K.; Zunic, V. Org. Lett. 2002, 4, 3465.
41. Cho, Y.-H.; Fayol, A.; Lautens, M. Tetrahedron: Asymmetry 2006, 17, 416.
42. Villeneuve, K.; Tam, W. J. Am. Chem. Soc. 2006, 128, 3514.
43. (a) Lautens, M.; Fagnou, K. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5455.
44. (b) Lautens, M.; Fagnou, K.; Yang, D. J. Am. Chem. Soc. 2003, 125, 14884.
45. (c) Fagnou, K.; Lautens, M. Angew. Chem. Int. Ed. 2002, 41, 26.
46. (d) Lautens, M.; Fagnou, K. J. Am. Chem. Soc. 2001, 123, 7170.
47. (a) Hayashi, T.; Yamamoto, A.; Hojo, M.; Kishi, K.; Ito, Y.; Nishioka, E.; Miura, H.; Yanagi, K. J. Organomet. Chem. 1989, 370, 129.
48. (b) Schwink, L.; Knochel, P. Chem. Eur. J. 1998, 4, 950.
49. 2-Ferriphos would be required to ensure high enantioselectivity in the catalytic ring-opening reaction.
50. (a) Orsini, F.; Selloa, G.; Bestettib, G. Tetrahedron: Asymmetry 2001, 12, 2961.
51. (b) Mukoyama, M.; Imagawa, K.; Hata, E.; Yamada, T. Jpn. Kokai Tokkyo Koho, JP 10095753, 1998; Chem. Abstr. 1998, 128, 243824.
52. (c) Imagawa, K.; Hata, E.; Yamada, T.; Mukaiyama, T. Chem. Lett. 1996, 291.
53. (d) D'Andrea, S. V.; Freeman, J. P.; von Voigtlander, P. F.; Szmuszkovicz, J. Tetrahedron 1991, 47, 6157.
54. (e) Saito, M.; Kayama, Y.; Watanabe, T.; Fukushima, H.; Hara, T.; Koyano, K.; Takenaka, A.; Sasada, Y. J. Med. Chem. 1980, 23, 1364.
55. (a) Comprehensive Organometallic Chemistry, Vol. 5; Wilkinson, G., Ed.; Pergamon Press: London, 1982.
56. (b) Fu, G. C.; Nguyen, S. T.; Grubbs, R. H. J. Am. Chem. Soc. 1993, 115, 9856.
57. (c) Bazan, G. C.; Oskam, J. H.; Cho, H.-N.; Park, L. Y.; Schrock, R. R. J. Am. Chem. Soc. 1991, 113, 6899.
58. (d) Schrock, R. R.; Murdzek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; O'Regan, M. J. Am. Chem. Soc. 1990, 112, 3875.
59. 2 and the insoluble precipitate was filtered off again. After removal of all volatile substrates, the corresponding iodide (quantitative yield) was obtained.
60. 2 with anisotropic thermal parameters for the non-hydrogen atoms led to agreement factors R1 = 0.0360 and wR2 = 0.0887. Crystallographic data for the structure 4 reported in this paper have been deposited at the Cambridge Crystallographic Data Centre as supplementary material No. CCDC-639749. Copies of the data may be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK (fax: +44 1223 33603 or e-mail: deposit@ccdc.cam.ac.uk).
61. Chiral stationary phase columns (Chiralcel AS for 3b and AD for 3b′).
62. 2 with anisotropic thermal parameters for the nonhydrogen atoms led to agreement factors R1 = 0.0491 and wR2 = 0.1115. Crystallographic data for the structure 3b reported in this paper have been deposited at the Cambridge Crystallographic Data Centre as supplementary material No. CCDC-639748. Copies of the data may be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK (fax: +44 1223 33603 or e-mail: deposit@ccdc.cam.ac.uk).
63. (a) Maury, C.; Gharbaoui, T.; Royer, J.; Husson, J.-P. J. Org. Chem. 1996, 61, 3687.
64. (b) Denis, J.-N.; Correa, A.; Greene, A. E. J. Org. Chem. 1991, 56, 6939.
65. (a) Honda, T.; Wakabayashi, H.; Kanai, K. Chem. Pharm. Bull. 2002, 50, 307.
66. (b) Van der Sluis, M.; Dalmolen, J.; De Lange, B.; Kaptein, B.; Kellogg, R. M.; Broxterman, Q. B. Org. Lett. 2001, 3, 3943.
67. Lautens, M.; Schmid, G. A.; Chau, A. J. Org. Chem. 2002, 67, 8043.
68. Chiral stationary phase columns (Chiralcel AD for 9).